Cannasouth’s aim is to produce Premium-Plus cannabis-based medicine to treat and support the health of patients suffering from a variety of conditions.
Cannasouth have completed and commissioned the new state-of-the-art (and unique to New Zealand), sealed controlled-environment greenhouse and processing facility and obtained both GACP and GMP licenses for the facility.
Cannasouth has had a range of medicinal cannabis products verified by the New Zealand Medicinal Cannabis Agency.
All of our medicinal cannabis products are produced under strict GMP regulations here in New Zealand and we offer unique combinations and ratios of cannabinoids, designed to address the differing medical needs of patients.
Our imported, Cannasouth-branded medicines are produced under GMP as well, and in similar formulations as our New Zealand made Cannasouth-manufactured product range.
If you are a Health Care Professional and would like to enquire about our products, or if you are interested in importing our GACP/GMP medicinal cannabis flower, GMP cannabinoid-based medicines, API’s or CBI’s, please fill out the form on our Export and Sales page.